OneMedNet Corporation (ONMD)
Healthcare • Health Information Services
StockNasdaqCMUnited StatesUS68270C2026
Kyvero is an independent information site. It is not affiliated with, endorsed by or sponsored by OneMedNet Corporation, and has no access to any account you may have with it. The name and the logo belong to their owners.
Price history
Daily prices in USD. Dividends, results and news are marked on the day they happened; click a day to see them.
Updated 13 Nov 2026 15:30. Information, not advice. Showing the last 12 months. Create a free account to see the whole history
Results
Annual results · USD
| Year | Revenue | Change | Net income | Net margin | EPS | EPS change | Free cash flow |
|---|---|---|---|---|---|---|---|
| 2025 | 1.4M | +111.4% | -2.8M | -206.1% | -0.06 | +83.3% | -7.5M |
| 2024 | 643K | -37.0% | -10.1M | -1,575.3% | -0.36 | +92.3% | -7M |
| 2023 | 1M | -11.4% | -33.8M | -3,308.5% | -4.65 | +38.4% | -4.8M |
| 2022 | 1.2M | — | -30.5M | -2,641.0% | -7.55 | — | -4.8M |
Dates and earnings per share from the company reports as collected by the data provider; the estimate is the analysts' average before the report. Information, not advice.
Prices by day, week and month
| Period | Opening price | High | Low | Closing price | Change | Volume | Dividend |
|---|---|---|---|---|---|---|---|
| Nov 2026 In progress | 4.16 | 6.19 | 4.11 | 5.33 | +26.18% | 237,931 | |
| Oct 2026 | 5.71 | 5.79 | 3.61 | 4.22 | -27.05% | 737,300 | |
| Sep 2026 | 5.78 | 7.80 | 5.20 | 5.79 | -1.78% | 1,277,120 | |
| Aug 2026 | 6.84 | 8.10 | 5.62 | 5.89 | -18.19% | 1,056,940 | |
| Jul 2026 | 6.89 | 8.27 | 5.60 | 7.20 | +1.27% | 4,887,330 | |
| Jun 2026 | 7.60 | 8.00 | 4.90 | 7.11 | -7.78% | 868,590 | |
| May 2026 | 10.60 | 11.10 | 7.35 | 7.71 | -28.61% | 602,070 | |
| Apr 2026 | 8.92 | 12.70 | 7.80 | 10.80 | +27.06% | 1,936,500 | |
| Mar 2026 | 9.24 | 9.70 | 6.00 | 8.50 | -16.67% | 1,908,030 | |
| Feb 2026 | 7.40 | 14.00 | 5.70 | 10.20 | +33.51% | 22,224,020 | |
| 51 older periods: create a free account to see the whole history | |||||||
Prices in USD, adjusted for splits but not for dividends. Weeks run Monday to Friday and months follow the calendar; the change compares each close with the previous period's. Dividends are those whose ex-dividend date falls in the period, per share. Information, not advice.
News
- OneMedNet Reports $18.76 Million in Year-to-Date of Contracted Bookings and Publishes “OneMedNet by the Numbers” Growth Recap (opens in a new tab) 09 Nov 2026 14:00
- OneMedNet Partners to Combine First-Party Multimodal Clinical Data with Comprehensive Patient-Journey AI Analytics, Expanding Commercial Reach Through 13th Channel Partnership (opens in a new tab) 09 Nov 2026 13:00
- OneMedNet Reports Preliminary Revenue for Third Quarter 2026 and Fourth Quarter 2026 Outlook (opens in a new tab) 06 Nov 2026 13:30
- OneMedNet Reports QQ3 Preliminary Revenue Of ~$1M, Up 465% YoY; Anticipates Q4 Revenue Range $12M - $14M (opens in a new tab) Benzinga · 06 Nov 2026 09:34
- OneMedNet Receives Mid Six-Figure Re-Order from Foundation Model Company Developing Radiology Models (opens in a new tab) 04 Nov 2026 13:45
- OneMedNet Receives Six-Figure Reorder From Undisclosed Foundation Model Firm Developing AI Models For Radiology (opens in a new tab) Benzinga · 04 Nov 2026 09:46
- OneMedNet Receives High Six-Figure Add-On Order Under Multiyear Agreement Announced September 30 (opens in a new tab) 03 Nov 2026 13:40
Headlines link to the original articles of the publishers shown; Kyvero does not write, check or endorse them. Only the most relevant news about each company is kept. Information, not advice.
Key data
- Previous close
- 5.35 USD
- Market cap
- 31.0M
- Exchange
- NasdaqCM
- Country
- United States
- Sector
- Healthcare
- Industry
- Health Information Services
- Currency
- USD
Dividends
No dividends on record.
Why this score
| Part of the score | Points | Why |
|---|---|---|
| Business growth Yearly growth of revenue and of earnings per share. | 9.4 / 25 |
|
| Quality Return on equity, net margin and how stable the margins are. | 0.0 / 25 | — |
| Financial strength Net debt against operating earnings, interest cover and free cash flow. | 0.0 / 20 |
|
| Valuation Free cash flow yield and the P/E against its sector. | 0.0 / 15 |
|
| Analysts How far the analysts' average target is from today's price. | 3.5 / 10 No figures for this part: it counts as a cautious 35%. | — |
- Score capped at 60: free cash flow was negative in two of the last three years
- Thin interest cover: operating profit is only -144.3× the interest
- The last full year was a loss
Growth profile: it pays no dividend, so it is scored on business growth, quality and financial strength. Based on 85% of the figures (grade B). Warnings take 12 points off.
Warnings take points off and some cap the score. In your account the score also considers how the share fits your portfolio. How the score works
Figures
| Figure | Value | Reading | Sector median |
|---|---|---|---|
| Price / book | -8.82× | Weak | 3.5× |
| Price / sales | 21.5× | Weak | 3.33× |
| EV / EBITDA | -3.19× | Weak | 11.19× |
| Free cash flow yield | -13.5% | Weak | 2.1% |
| Figure | Value | Reading | Sector median |
|---|---|---|---|
| Gross margin | -83.3% | Weak | 54.9% |
| Operating margin | -696.2% | Weak | 5.8% |
| Net margin | 0% | Weak | 1.2% |
| Return on assets | -342.1% | Weak | 2.7% |
| Figure | Value | Reading | Sector median |
|---|---|---|---|
| Revenue growth / year | 5.6% | Fair | 10.1% |
| Figure | Value | Reading | Sector median |
|---|---|---|---|
| Debt / equity | -0.19× | Good | 0.4× |
| Interest cover | -144.28× | Weak | 2.17× |
| Current ratio | 0.28× | Weak | 2.64× |
The reading follows general rules of thumb and each sector has its own norms: compare with the sector median when it is shown. Information, not advice.
Similar shares
Follow ONMD and get alerts
Create a free account to add it to your watchlist, set a price alert, see how it fits your portfolio and track your dividends.